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Abstract
Background: The healthcare system of mainland China is undergoing drastic reform and the optimal models for healthcare
financing for provision of primary care will need to be identified. This study compared the performance indicators of the
community health centres (CHCs) under different healthcare financing systems in the six cities of the Pearl River Delta
region.
Methods: Approximately 300 hypertensive patients were randomly recruited from the computerized chronic disease
management records provided by one CHC in each of the six cities in 2011 using a multi-stage cluster random sampling
method. The major outcome measures included the treatment rate of hypertension, defined as prescription of $ one
antihypertensive agent; and the control rate of hypertension, defined as systolic blood pressure levels ,140 mmHg and
diastolic blood pressure levels ,90 mmHg in patients without diabetes mellitus, or ,130/80 mmHg among patients with
concomitant diabetes. Binary logistic regression analyses were conducted with these two measures as outcome variables,
respectively, controlling for patients’ socio-demographic variables. The financing system (Hospital- vs. Government- vs.
private-funded) was the independent variable tested for association with the outcomes.
Results: From 1,830 patients with an average age of 65.9 years (SD 12.8), the overall treatment and control rates were 75.4%
and 20.2%, respectively. When compared with hospital-funded CHCs, patients seen in the Government-funded (adjusted
odds ratio [AOR] 0.462, 95% C.I. 0.325–0.656) and private-funded CHCs (AOR 0.031, 95% C.I. 0.019–0.052) were significantly
less likely to be prescribed antihypertensive medication. However, the Government-funded CHC was more likely to have
optimal BP control (AOR 1.628, 95% C.I. 1.157–2.291) whilst the privately-funded CHC was less likely to achieve BP control
(AOR 0.146, 95% C.I. 0.069–0.310), irrespective of whether antihypertensive drugs were prescribed.
Conclusions: Privately-funded CHCs had the lowest rates of BP treatment and control due to a variety of potential factors as
discussed.
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Introduction
Primary care was defined by the WHO as the ‘‘the first level of
contact of individuals, the family and the community with the
national health system, bringing health care as close as possible to
where people live and work’’ [1]. A substantial body of evidence
around the world has suggested that primary care, in contrast to
specialty care, is associated with lower morbidity and mortality as
well as more equitable distribution of health within and across
populations [2]. Health systems with more primary care orienta-
tion could lead to better health outcomes, induce lower healthcare
costs, and enhance patient satisfaction [3,4]. The WHO has
therefore emphasized the urgency of enhancing primary care [5],
and it is widely recognized that healthcare reforms need to begin
with primary care [2]. From the global perspective, there is an
international trend of health policy orientation towards developing
primary care as a priority of health reforms to improve health
outcomes [6]. These include European countries, Brazil, Australia
and Asia-Pacific countries [7–10].
In early 2009, the Chinese government initiated a comprehen-
sive healthcare reform [11] which stands on four key pillars,
including healthcare financing, care delivery, drug supply, and
hospital reforms. Initiatives to systematically strengthen commu-
nity-based primary care services are being put at the top of the
agenda to underpin the care delivery pillar in order to provide
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universally accessible services at affordable prices to those in need.
The set up of community health centres (CHCs) in nearly every
neighbourhood in urban areas has been particularly prominent as
a new initiative to address a broad range of patients’ healthcare
needs by providing community health services.
CHCs in each city of the Pearl River Delta (PRD) region of
China were operated by one of the three distinct healthcare
financing systems, namely hospital-, Government- and private-
funding, defined by the source of budgeting and ownership. The
PRD refers to the network of 6 cities in the Guangdong province.
It has a total population of 43.1 million in 2010 [12], and is the
leading economic region and main hub of China’s economic
growth [13]. This region enables researchers a unique opportunity
to study the strengths and weaknesses of different healthcare
delivery models. However, there is a scarcity of studies which
compared the performance of primary care delivered by these
different models. Identifying the financing model that leads to
better health outcomes could inform policy-makers on the future
planning and implementation of health delivery strategies.
The government plays a dominant role in financing and
ownership in the health sector in China. Government-owned
CHCs are established by and subject to the local government as
non-profit healthcare facilities which are detached from hospitals
[14]. Local government operates and manages the CHCs
exclusively, whereas the local health bureau provides professional
guidance, industrial monitoring and assessment to guarantee the
quality of service provision. Hospital-owned CHCs have a tight
relationship with various types of non-private hospitals, and the
host public hospitals are responsible for daily operation and
administration of the CHCs, with the provision of healthcare
professionals, salary, medical equipments, technique support,
funding resource managed in an integrative approach [15,16].
Privately-owned CHCs are established, owned, and operated by
private/social investors along with local government and hospitals
to provide comparable primary care services [17].
The management of hypertension, one of the most commonly
encountered chronic conditions in primary care, has been widely
accepted as a recognized proxy measure of clinical performance
[14–15]. The treatment and blood pressure (BP) control rates
among hypertensive patients are valid across localities and
countries, and have been used extensively as outcome indicators
for assessing the quality of healthcare systems [16]. The objective
of this study is to compare the performance of the three major
healthcare financing systems in the PRD region using manage-
ment of hypertension as an outcome measure. We tested the a
priori hypothesis that there exist differences in the performance
among these three financing models.
Materials and Methods
Ethics Statement
This study was approved by the Survey and Behavioral
Research Ethics Committee of the Faculty of Medicine, Chinese
University of Hong Kong.
Data Source & Sampling Methodology
The computerized chronic disease management records were
used to retrieve data on the management of patients with
hypertension by primary care providers in the CHCs of the cities
under study. The data for the outcome part were retrieved from a
previous ‘‘Community-wide Household Health Assessment
(CHHA) Project’’, which collected healthcare records of adult
residents who hold the ‘‘Hukou’’ registry from 5% of the general
population in the six cities of Pearl River Delta in 2010. ‘‘Hukou’’
registry refers to those who have relatively more permanent
residence, and is a household registration related to the migration
control and resource distribution under China’s residential policy.
Its registration entitled people the access to basic social services,
old-age welfare, subsidized housing, more opportunities for
employment, and free public education in their specific registered
area. Multistage cluster random sampling method was adopted in
retrieving the data in the current study, as this is more feasible and
easier to coordinate. In each city, one district was randomly
selected as the ‘‘Primary Sampling Units’’ (PSU). One neighbor-
hood was selected by simple random sampling as the ‘‘Secondary
Sampling Units’’ (SSU) within the district. One CHC was selected
by simple random sampling as the ‘‘Tertiary Sampling Units’’
(TSU) within the neighborhood (Table 1). From all the eligible
hypertensive patients in each selected CHC, approximately 300
patients were included in the study by simple random sampling
with one patient being counted as one unit of randomization. For
each patient, a unique identifier ‘‘1, 2, 3…etc.’’ was assigned
according to their citizen card number, which served the purpose
to anonymize individual information and protected patients from
being identified.
Study Participants
The study period was January to October, 2010. The inclusion
criteria used in selecting subjects for this study include 1). patients
who had identifiable primary care providers and who were
previously service users in the selected CHCs; 2). those who
received a diagnosis of hypertension by the primary care
physicians in the selected CHCs; and 3). those who have been
living in the neighborhood covered by the selected CHCs for at
least 1 year, in order to include subjects with adequately long
periods for continuity of clinical care.
Outcome Measures and Covariates
The primary outcomes include 1). treatment of hypertension,
defined as the prescription of at least one medication within the
major antihypertensive drug classes in the study period of 2010;
and 2). control of hypertension, defined as an average of two blood
pressure levels measured in the CHCs being ,140 mmHg
(systolic) and ,90 mmHg (diastolic) in patients without diabetes.
For each patient, we used the average of the first two BP values in
the calendar year 2010. In the presence of diabetes, levels of
,130 mmHg (systolic) and ,80 mmHg (diastolic) were adopted
according to the recommendations of the Joint National Com-
mittee 7th report [17].
The covariates include patients’ age, gender, occupation
(employed vs. unemployed vs. retired or others), educational
status (primary or lower vs. secondary vs. tertiary or above),
presence of medical insurance coverage, marital status (single vs.
married vs. divorced/separated/widowed) and body mass index.
The insurance system and the amount of insurance coverage on
fees from clinical examination, medical treatment, and medication
costs were in general of similar magnitude when compared among
CHCs in these cities [18]; whilst there are some conditions that
could influence the proportion of insurance reimbursement for
each individual, including the severity of the medical condition,
insurance category of the drugs, whether the healthcare facilities
where healthcare expenditures occurred are enlisted in the
insurance, employment status and hierarchy, etc. [19]. The
predictor variable tested for association with the two outcome
variables was the financing type of the CHCs (Government vs.
hospital vs. private-funding). It was hypothesized that there exists
difference in the performance indicators among the different
CHCs funded under the three distinct financing models.
Healthcare Financing System and Clinical Outcomes
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Statistical Analysis
The Statistical Package for Social Sciences (SPSS) version 15.0
was used for all data entry and analysis. The demographic and
clinical characteristics of patients under each CHC were
compared by x2 tests of heterogeneity and Student’s t-tests for
categorical and continuous variables, respectively. The treatment
and control rates of the six CHCs were expressed in proportions
and compared. Two separate binary logistic regression models
were constructed with treatment and control of hypertension as
outcome variables, respectively. An additional regression model
was conducted with presence of antihypertensive treatment as a
covariate and BP control as an outcome variable. The above
analysis was run again by merging the four hospital-managed
CHCs (in cities A to D) as one group under ‘‘hospital-funding’’. To
evaluate the independent association between the outcome
variables and the financing system, all covariates were entered
into the regression analyses. P values ,0.05 were regarded as
statistically significant.
Results
Patient Characteristics
The demographic characteristics of the patients were shown in
Table 2. The average age of the study subjects was 65.9 years (SD
12.8). Male patients consist of 48.6%. Only 21.6% of the
participants were employed full-time. The majority received
primary education or below (51.8%). Most were married
(93.8%) and under medical insurance (62.4%). Approximately
13.3% had concomitant diabetes mellitus at the time of the survey,
and the mean duration of hypertension was 5.7 years (SD 6.3).
Their average systolic and diastolic BP levels were 147.6 and
88.4 mmHg, respectively. They had an average BMI of 24.1 kg/
m2. There were significant heterogeneity among the six cities
according to all the demographic and clinical variables (all
p,0.001).
Treatment and Control Rates
The overall treatment and control rates of all patients were
75.4% and 20.2%, respectively (Table 3). Among patients on
antihypertensive drug treatment, the BP control rate was 23.8%.
Hospital-funded CHCs had the highest treatment (range: 83.1%–
92.1%) rates, followed by Government (70.3%) and privately-
funded CHCs (29.9%). The BP control rates were highest among
the Government-funded CHC (25.8%), followed by hospital-
funded CHCs (22.7%, range 20.1%–26.7%) and the privately
funded CHC (8.9%). This is similarly found among patients on
antihypertensive treatment, where the control rates were higher in
the Government-funded CHC (33.0%) than hospital-funded
(23.2%, range 20.1%–28.9%) and private-funded CHC (8.9%).
Factors Associated with Antihypertensive Treatment and
Optimal BP Control
Table 4 shows the association between treatment and
control of hypertension, respectively, with the various CHCs
when the potential confounders were controlled. It was found
that when compared with city A, patients seen in city C (aOR
2.865, 95% C.I. 1.612–5.095, p,0.001) were more likely to
receive an antihypertensive medication, whereas patients in city
E (adjusted odds ratio [aOR] 0.627, 95% C.I. 0.393–1.000,
p = 0.050) and city F (aOR 0.038, 95% C.I. 0.021–0.068,
p,0.001) were less likely to be offered antihypertensive
treatments. In addition, CHCs in city C (aOR 1.641, 95%
C.I. 1.052–2.560, p= 0.029) and city E was significantly more
likely (aOR 2.231, 95% C.I. 1.406–3.538, p= 0.001) while city
F significantly less likely (aOR 0.184, 95% C.I. 0.083–0.411,
p,0.001) to have optimal blood pressure control among
hypertensive patients. When the regression analysis was re-
conducted with antihypertensive treatment included as a
covariate, similar findings were obtained. Patients in city E
were more likely (aOR 2.401, 95% C.I. 1.502–3.838, p,0.001)
and in city F less likely to achieve optimal BP control (aOR
0.296, 95% C.I. 0.127–0.691, p= 0.005) (Table 5).
When the regression model was re-constructed by classifying
the CHCs according to the financing model with hospital-
funded CHC as a reference (Table 5), the Government-funded
(aOR 0.462, 95% C.I. 0.325–0.656, p,0.001) and private-
funded CHCs (aOR 0.031, 95% C.I. 0.019–0.052, p,0.001)
were associated with lower treatment rates. However, Govern-
ment-funded CHCs were significantly more likely (aOR 1.628,
95% C.I. 1.157–2.291, p,0.001) and private-funded CHC less
likely (aOR 0.146, 95% C.I. 0.069–0.310, p,0.001) to achieve
optimal BP control than hospital-funded CHCs. When antihy-
pertensive treatment was included as a covariate in the
regression analysis with BP control as the outcome, similar
findings on the comparisons of CHCs according to the
financing models were observed (Table 5). These findings
Table 1. The characteristics of the six cities under study.
City A B C D* E F
Type Provincial Capital Prefectural level city Prefectural level city Special Economic
Zone
Prefectural level city Special Economic Zone
Primary Care
Providers
Hospital- owned
CHC
Hospital- owned CHC Hospital- owned CHC Hospital- owned CHC Government- owned CHC Privately- owned CHC
No. of CHCs 118 45 28 68 32 10
No. of districts 11 5 28 8 32 10
No. of PSU 1 1 1 1 1 1
No. of SSU 1 1 1 1 1 1
No. of TSU 1 1 1 1 1 1
No. of Total
Subjects
305 301 302 309 300 303
*The number of CHCs in city D is counted according to the number of host hospitals. PSU: Primary Sampling Units; SSU: Secondary Sampling Units; TSU: Tertiary
Sampling Units; CHC: Community Health Centre.
doi:10.1371/journal.pone.0046309.t001
Healthcare Financing System and Clinical Outcomes
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reflected significant differences in the general population among
these communities, but implied that the regression analyses
could control for these inter-city differences as the associated
factors were similarly significant when models were constructed
using different variables.
Other Factors Associated with Blood Pressure
Management
Older age was associated with prescriptions of antihypertensive
treatment (AOR 1.035, 95% C.I. 1.022–1.049 per one mmHg
increase of BP, p,0.001) and BP control (AOR 1.013, 95% C.I.
Table 2. Patient Characteristics (N = 1,830).
Hospital Funded Govt funded
Private
funded All patients p**
A B C D E F
(n =309) (n=302) (n =305) (n=303) (n =310) (n=301)
Age* 69.8 67.4 66.9 69.3 65.3 56.9 65.9 ,0.001
(years) 210.4 210.7 210.2 212.8 214.1 213.4 212.8
Gender
Male 138 (44.7) 135 (44.7) 152 (49.8) 130 (42.9) 143 (46.1) 191 (63.5) 889 (48.6) ,0.001
Female 171 (55.3) 167 (55.3) 153 (50.2) 173 (57.1) 167 (53.9) 110 (36.5) 941 (51.4)
Occupation
Employed 37 (12.5) 99 (32.8) 24
(7.9)
47 (38.2) 49
(15.8)
72
(38.9)
328 (21.6) ,0.001
Unemployed 71 (23.9) 97 (32.1) 203 (66.8) 23 (18.7) 165 (53.2) 49
(26.5)
608 (40.0)
Retired/others 189 (63.6) 106 (35.1) 77 (25.3) 53 (43.1) 96
(31.0)
64
(34.6)
585 (38.5)
Educational status
#Primary 82 (27.7) 210 (69.8) 204 (67.1) 23 (18.7) 230 (76.2) 33
(17.8)
782 (51.8) ,0.001
Secondary 148 (50.0) 75 (24.9) 84 (27.6) 69 (56.1) 71
(23.5)
111 (60.0) 558 (36.9)
$ Tertiary 66 (22.3) 16
(5.3)
16
(5.3)
31 (25.2) 1
(0.3)
41
(22.2)
171 (11.3)
Marital status
Single 2 (0.7) 0 (0.0) 1 (0.3) 0 (0.0) 4 (1.3) 8 (4.3) 15 (1.0) ,0.001
Married 292 (98.3) 294 (97.4) 298 (98.0) 123 (100.0) 234 (78.3) 176 (95.1) 1417 (93.8)
Divorced 1 (0.3) 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.3) 0 (0.0) 2 (0.1)
Widowed 2 (0.7) 8 (2.6) 5 (1.6) 0 (0.0) 60 (20.1) 1 (0.5) 76 (5.0)
Medical insurance
No 52 (16.8) 56 (18.5) 148 (48.5) 234 (77.2) 74 (23.9) 124 (41.2) 688 (37.6) ,0.001
Yes 257 (83.2) 246 (81.5) 157 (51.5) 69 (22.8) 236 (76.1) 177 (58.8) 1142 (62.4)
Presence of diabetes
No 260 (84.1) 273 (90.4) 243 (79.7) 280 (92.4) 274 (88.4) 257 (85.4) 1587 (86.7) ,0.001
Yes 49 (15.9) 29
(9.6)
62 (20.3) 23
(7.6)
36
(11.6)
44
(14.6)
243 (13.3)
Duration of hypertension* 7.7 5.6 6.2 5.4 5.3 4.6 5.7 ,0.001
(mean in years) 28.1 26.3 26.3 27.0 24.8 24.1 26.3
Mean SBP* 148.6 149.1 147.1 145.7 143.0 151.9 147.6 ,0.001
(mmHg) 215.3 214.6 215.7 214.0 216.9 212.1 215.1
Mean DBP* 87.3 87.0 86.3 86.6 86.0 97.6 88.4 ,0.001
(mmHg) 211.3 210.0 210.4 29.5 211.3 210.3 211.2
BMI* 24.6 24.0 24.3 23.2 24.9 23.6 24.1 ,0.001
(m/kg2) 23.4 23.5 23.3 22.8 24.1 22.8 23.4
SBP: Systolic Blood Pressure; DBP: Diastolic Blood Pressure; BMI: Body Mass Index. A to F represent selected community health centres in the six cities of the Pearl River
Delta region.
*Continuous variables;
**chi-square test for categorical variables and Student’s t-tests for continuous variable. The figures in the brackets represent standard deviations and percentages across
columns for continuous and categorical variables, respectively.
doi:10.1371/journal.pone.0046309.t002
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1.000–1.026, p = 0.043), but the latter association no longer exists
when antihypertensive treatment was included as a covariate
(Table 4). When compared with educational status at primary
level or below, patients having secondary (AOR 1.475, 95% C.I.
1.058–2.058, p = 0.022) and tertiary level or above (AOR 3.101,
95% C.I. 1.906–5.044, p,0.001) were more likely to have optimal
BP control (Table 4). In addition, people having higher body
mass index were less likely to have their BP controlled (AOR
0.951, 95% C.I. 0.915–9.989, p = 0.012), irrespective of whether
antihypertensive drug treatment was controlled. There was no
collinearity detected among the covariates tested in the regression
analyses.
Discussion
Major Findings
It was found that for treatment rates, hospital-funded CHCs
were significantly higher than the Government-funded CHCs,
followed by the privately-funded CHCs. For BP control rates, the
Government-funded CHCs were the highest, whilst privately-
funded CHCs had the lowest rate. Multivariate regression analysis
also demonstrated that the privately-funded CHC had the poorest
treatment and control rates of hypertension when potential
confounders were controlled. This holds true whether antihyper-
tensive treatment was controlled as a covariate in the regression
analyses. Another factor associated with antihypertensive treat-
ment included older age; while higher educational levels and lower
BMI were associated with better BP control.
Relationship to Literature and Explanation of Findings
From a recent survey among Tibetans hypertensive patients
aged $40 years living at high altitude, 2.6% received antihyper-
tensive treatment and only one patient out of 701 study
participants had optimal BP control [20]. Another recent study
involving more than 13,800 Southern Chinese aged $20 years
found that the treatment and control rates were 37.9% and 13.5%
in the urban regions, and were 10.4% and 3.4% in rural regions,
respectively [21]. Even lower control rates have been reported
among people in rural China (2%), urban India (12%) rural India
(9%) [22]. The treatment and control rates of BP in Beijing China
were found to be 35.9% and 11.5%, respectively [23]. Therefore
the management of hypertension as reported in this study achieved
better treatment and control rates than those evaluated by other
studies. Since our participants were recruited from clinics instead
of from the general population, it is not surprising to find these
outcome measures as more optimal.
There are obvious differences among the three types of CHCs
in terms of the source of financial support and the organizational
structure. For the Government-funded CHCs, these supports
include financial injections from the government annual budget
which includes public health funding, initial establishment
funding, equipment purchase, routine operating fees, staff costs
and other forms of funding. Whist the fees charged from patients
on clinical examination, medical treatment, drug sales, etc, which
serve as the revenue of government-funded CHCs mostly goes to
the local government. This particular feature renders the
government-funded CHCs the greatest degree of a non-profit
nature, which would reduce the possibility of excessive and
unnecessary prescription of drugs to patients in order to maximize
profits, as compared to hospital-funded CHCs and private-funded
CHCs which have to be financially self-sufficient under the current
market-orientated health system [24,25]. Hospital- and private-
funded CHCs in general receive a limited support on public health
funding from the government. These CHCs often generate more
profits largely from providing clinical medical services charged on
a fee-for-service basis. In addition, whilst all CHCs were subject to
industry supervision and monitoring from the Health Bureau to
ensure the quality of services provided, the Government-funded
CHCs had more connections with other Governmental agencies
[26]. Also, studies found pharmaceutical companies had strong
connections with secondary and tertiary hospitals, which are the
holding hospitals of the hospital-managed CHCs [27,28], and the
physicians working in the out-patients clinics of hospital-funded
CHCs were also used to working in secondary and tertiary sectors
at the same time, where drug prescriptions are more common in
management of chronic diseases than in the primary care sector.
One might therefore speculate that physicians in hospital-funded
CHCs could have lower threshold to prescribe antihypertensive
drugs as their usual practice. Primary care providers in the
Government-funded CHCs might not be as strongly incentivized
than hospital-funded CHCs to prescribe antihypertensive agents
during patient encounters where pharmacotherapy was not
perceived as a must e.g. when elevation in blood pressure was
only marginal which could be managed with educational and
lifestyle modification counseling before drug treatment. The
majority of profits made in Government-funded CHCs did not
contribute to clinic income whereas a significant proportion of
profit margins from consultations and prescriptions will go directly
Table 3. Treatment and Control Rates of hypertension in the Community Health Centres (CHCs) in the six cities of the Guangdong
Province.
City Type
Number of
patients Treatment Rate
Control Rate (all
patients)
Control Rate (among patients
with treatment)
A Hospital-funded 309 84.8% (262/309) 20.1% (62/309) 20.1% (51/262)
B Hospital-funded 302 83.1% (251/302) 21.5% (65/302) 20.7% (52/251)
C Hospital-funded 305 92.1% (281/305) 22.6% (69/305) 23.1% (65/281)
D Hospital-funded 303 91.4% (277/303) 26.7% (81/303) 28.9% (80/277)
E Government-funded 310 70.3% (218/310) 25.8% (80/310) 33.0% (72/218)
F Private-funded 301 29.9% (90/301) 4.3% (13/301) 8.9% (8/90)
Total 1,830 75.4% (1379/1830) 20.2% (370/1,830) 23.8% (328/1,379)
A to F represent selected community health centres in the six cities of the Pearl River Delta region. Treatment was defined as the prescription of at least one
antihypertensive agent; control was defined as systolic blood pressure ,140 mmHg and diastolic blood pressure ,90 mmHg; or ,130 mmHg and ,80 mmHg,
respectively in patients with diabetes mellitus.
doi:10.1371/journal.pone.0046309.t003
Healthcare Financing System and Clinical Outcomes
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into Hospital- and privately-funded CHCs. Furthermore, physi-
cians in privately-funded CHCs could be more hesitant to
prescribe medications if not absolutely necessary as this involves
extra payment from patients.
Nevertheless, greater proportions of patients in the Govern-
ment-funded CHCs had optimal BP control, despite their lower
treatment rates than the hospital-funded CHCs. One possibility is
that under the government-funded CHC model, primary care
service are provided directly from the local government, it leads to
stronger and better policy implementation. The Government-
funded CHCs creates a more robust chronic disease management
infrastructure including the establishment of clinical guidelines and
lifestyle modification initiatives [29]. The greater amount of
funding for the Government CHCs could translate into more
clinic-based programmes on self-management, like medication
compliance-enhancing intervention and lifestyle modification
initiatives. Further studies are warranted to explore whether there
exists differences in counseling practices for patients with chronic
diseases between CHCs with different financing modalities.
Moreover, there is also stronger emphasis of the Government-
funded CHCs on strengthening the role and responsibility of the
Government in optimizing partnership infrastructure and coordi-
native care among different primary care professionals for service
provision in the clinic, hence explaining its superior performance
in BP control.
Turning to the relationships between optimal BP control and
demographics like age, educational levels, BMI, the current
literature was mixed [23,30–32]. A recent study found that no
significant association was found with education and BMI for both
men and women, but women in the age groups 50 years and older
were significantly more likely to have controlled hypertension [30].
A study conducted in Beijing, China demonstrated a clear
relationship between poor hypertension control with older age,
lower educational attainment and central obesity [23]. The
explanations of these associations have been extensively discussed
elsewhere [23,30–32].
Strengths and Limitations
This is the first study which directly compared the healthcare
financing systems in the PRD region by adopting a random
sampling methodology in the selection of CHCs. However, some
limitations should be mentioned. Firstly, we recruited only one
CHC from each city and the sample size is modest, although the
sampling was conducted in a systematic manner using random
sampling methodology. In addition, we have included the
management of one chronic condition as the outcome indicator
for this comparison study, and the performance of other aspects
such as preventive services, treatment of acute conditions, patients’
quality of life and longer-term health outcomes have not been
evaluated. Also, we excluded patients who lived in their respective
districts for less than one year. Since it is likely that a significant
proportion of these more mobile residents were migrants, the
generalizability of our study findings to them might be limited.
Moreover, there are other factors apart from the healthcare system
which could influence blood pressure control. These factors might
be patient-related, such as dietary or exercise habits, smoking,
alcohol drinking the severity of hypertension, and specific cultural
attitudes to management of hypertension as a disease entity.
Clinic- or physician-related factors include accessibility to
healthcare, the time since the diagnosis of hypertension, the
availability of different types of antihypertensive medications in the
practice, the size of the CHCs, the number of clinic staff and the
presence of treatment guidelines. The differences in proportion of
migrants, which represent a more underprivileged group, could
also be contributory. These factors have not been controlled in our
regression models. Finally, ascertainment bias of blood pressure
measurement among these cities should be addressed.
Implications for Policy-making and Future Perspectives
We concluded that the privately-funded CHCs attained poorest
healthcare outcomes when compared with other CHCs in this
study but there exists factors other than the financing system which
might confound the outcome we measured. The reasons of the
poorer performance among the privately funded CHCs will
require further exploration, including evaluation of components
within the private financing model which might lead to poorer
patient management. On the contrary, the strengths of the hospital
and Government-funded system will need to be explored,
including the quality of supervision and quality of care in addition
to resources available to the different types of CHCs. Another
implication is that the clinical guidelines and better lifestyle
modification initiatives seen in Government-funded CHCs could
be potentially replicated in the Hospital- and privately-funded
CHCs. Furthermore, comparisons of these financing systems using
other tracer markers could further inform policy-makers on future
healthcare policy-making and health service implementation. For
healthcare reforms involving health system design, it is recom-
mended that the policy-makers analyze the essential key success
factors which could lead to better health outcomes.
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